List of Hetero Drugs Limited patents

List of Hetero Drugs Limited patents

List of Sage Science patents

List of Waterworks patents

List of Apkudo patents

List of companies in CrossCut Ventures's investment portfolio

Films directed by F. W. Murnau

Patents where

Current Assignee

Name

is

Hetero Drugs Limited

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 7365206 Stereoselective synthesis of benzimidazole sulfoxides	Patent 7365206 was granted and assigned to Hetero Drugs Limited on April, 2008 by the United States Patent and Trademark Office.		Hetero Drugs Limited		United States Patent and Trademark Office	7365206	April 29, 2008
	‌ US Patent 7638634 Amorphous esomeprazole hydrate	Patent 7638634 was granted and assigned to Hetero Drugs Limited on December, 2009 by the United States Patent and Trademark Office.		Hetero Drugs Limited		United States Patent and Trademark Office	7638634	December 29, 2009
	‌ US Patent 7067675 Process for ezetimibe intermediate	Patent 7067675 was granted and assigned to Hetero Drugs Limited on June, 2006 by the United States Patent and Trademark Office.		Hetero Drugs Limited		United States Patent and Trademark Office	7067675	June 27, 2006
	‌ US Patent 7361770 Process for preparation of valsartan	Patent 7361770 was granted and assigned to Hetero Drugs Limited on April, 2008 by the United States Patent and Trademark Office.		Hetero Drugs Limited		United States Patent and Trademark Office	7361770	April 22, 2008
	‌ US Patent 7687658 Process for oseltamivir phosphate	Patent 7687658 was granted and assigned to Hetero Drugs Limited on March, 2010 by the United States Patent and Trademark Office.		Hetero Drugs Limited		United States Patent and Trademark Office	7687658	March 30, 2010
	‌ US Patent 8669265 Hydrated form of erlotinib free base and a process for preparation of erlotinib hydrochloride polymorph form a substantially free of polymorph form B	Patent 8669265 was granted and assigned to Hetero Drugs Limited on March, 2014 by the United States Patent and Trademark Office.		Hetero Drugs Limited		United States Patent and Trademark Office	8669265	March 11, 2014
	‌ US Patent 8389531 Process for erlotinib hydrochloride	Patent 8389531 was granted and assigned to Hetero Drugs Limited on March, 2013 by the United States Patent and Trademark Office.		Hetero Drugs Limited		United States Patent and Trademark Office	8389531	March 5, 2013
	‌ US Patent 8106210 Polymorphs of esomeprazole salts	Patent 8106210 was granted and assigned to Hetero Drugs Limited on January, 2012 by the United States Patent and Trademark Office.		Hetero Drugs Limited		United States Patent and Trademark Office	8106210	January 31, 2012
	‌ US Patent 7947840 Process for preparation of enantiomerically pure esomeprazole	Patent 7947840 was granted and assigned to Hetero Drugs Limited on May, 2011 by the United States Patent and Trademark Office.		Hetero Drugs Limited		United States Patent and Trademark Office	7947840	May 24, 2011
	‌ US Patent 8173817 Stereoselective synthesis of benzimidazole sulfoxides	Patent 8173817 was granted and assigned to Hetero Drugs Limited on May, 2012 by the United States Patent and Trademark Office.		Hetero Drugs Limited		United States Patent and Trademark Office	8173817	May 8, 2012
	‌ US Patent 7732632 Process for obtaining pure oseltamivir	Patent 7732632 was granted and assigned to Hetero Drugs Limited on June, 2010 by the United States Patent and Trademark Office.		Hetero Drugs Limited		United States Patent and Trademark Office	7732632	June 8, 2010
	‌ US Patent 7629482 Process for preparation of cefprozil intermediate	Patent 7629482 was granted and assigned to Hetero Drugs Limited on December, 2009 by the United States Patent and Trademark Office.		Hetero Drugs Limited		United States Patent and Trademark Office	7629482	December 8, 2009
	‌ US Patent 7858812 Process for isolation of desired isomers of nebivolol intermediates	Patent 7858812 was granted and assigned to Hetero Drugs Limited on December, 2010 by the United States Patent and Trademark Office.		Hetero Drugs Limited		United States Patent and Trademark Office	7858812	December 28, 2010
	‌ US Patent 8227431 Nucleoside derivatives	Patent 8227431 was granted and assigned to Hetero Drugs Limited on July, 2012 by the United States Patent and Trademark Office.		Hetero Drugs Limited		United States Patent and Trademark Office	8227431	July 24, 2012
	‌ US Patent 8242267 Polymorphs of efavirenz	Patent 8242267 was granted and assigned to Hetero Drugs Limited on August, 2012 by the United States Patent and Trademark Office.		Hetero Drugs Limited		United States Patent and Trademark Office	8242267	August 14, 2012
	‌ US Patent 8361507 Eprosartan mesylate crystalline particles and a process for preparing pure eprosartan	Patent 8361507 was granted and assigned to Hetero Drugs Limited on January, 2013 by the United States Patent and Trademark Office.		Hetero Drugs Limited		United States Patent and Trademark Office	8361507	January 29, 2013
	‌ US Patent 8466279 Polymorphs of efavirenz	Patent 8466279 was granted and assigned to Hetero Drugs Limited on June, 2013 by the United States Patent and Trademark Office.		Hetero Drugs Limited		United States Patent and Trademark Office	8466279	June 18, 2013
	‌ US Patent 8471012 Hydrated form of erlotinib free base and a process for preparation of erlotinib hydrochloride polymorph form a substantially free of polymorph form B	Patent 8471012 was granted and assigned to Hetero Drugs Limited on June, 2013 by the United States Patent and Trademark Office.		Hetero Drugs Limited		United States Patent and Trademark Office	8471012	June 25, 2013
	‌ US Patent 7053115 Crystalline form of dorzolamide hydrochloride	Patent 7053115 was granted and assigned to Hetero Drugs Limited on May, 2006 by the United States Patent and Trademark Office.		Hetero Drugs Limited		United States Patent and Trademark Office	7053115	May 30, 2006

19 results

0 selected

19 results

0 selected